UniProt ID | HDAC1_MOUSE | |
---|---|---|
UniProt AC | O09106 | |
Protein Name | Histone deacetylase 1 | |
Gene Name | Hdac1 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 482 | |
Subcellular Localization | Nucleus . | |
Protein Description | Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Deacetylates SP proteins, SP1 and SP3, and regulates their function. Component of the BRG1-RB1-HDAC1 complex, which negatively regulates the CREST-mediated transcription in resting neurons. Upon calcium stimulation, HDAC1 is released from the complex and CREBBP is recruited, which facilitates transcriptional activation. Deacetylates TSHZ3 and regulates its transcriptional repressor activity. Deacetylates 'Lys-310' in RELA and thereby inhibits the transcriptional activity of NF-kappa-B. Deacetylates NR1D2 and abrogates the effect of KAT5-mediated relieving of NR1D2 transcription repression activity. Component of a RCOR/GFI/KDM1A/HDAC complex that suppresses, via histone deacetylase (HDAC) recruitment, a number of genes implicated in multilineage blood cell development. Involved in CIART-mediated transcriptional repression of the circadian transcriptional activator: CLOCK-ARNTL/BMAL1 heterodimer. Required for the transcriptional repression of circadian target genes, such as PER1, mediated by the large PER complex or CRY1 through histone deacetylation.. | |
Protein Sequence | MAQTQGTKRKVCYYYDGDVGNYYYGQGHPMKPHRIRMTHNLLLNYGLYRKMEIYRPHKANAEEMTKYHSDDYIKFLRSIRPDNMSEYSKQMQRFNVGEDCPVFDGLFEFCQLSTGGSVASAVKLNKQQTDIAVNWAGGLHHAKKSEASGFCYVNDIVLAILELLKYHQRVLYIDIDIHHGDGVEEAFYTTDRVMTVSFHKYGEYFPGTGDLRDIGAGKGKYYAVNYPLRDGIDDESYEAIFKPVMSKVMEMFQPSAVVLQCGSDSLSGDRLGCFNLTIKGHAKCVEFVKSFNLPMLMLGGGGYTIRNVARCWTYETAVALDTEIPNELPYNDYFEYFGPDFKLHISPSNMTNQNTNEYLEKIKQRLFENLRMLPHAPGVQMQAIPEDAIPEESGDEDEEDPDKRISICSSDKRIACEEEFSDSDEEGEGGRKNSSNFKKAKRVKTEDEKEKDPEEKKEVTEEEKTKEEKPEAKGVKEEVKLA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
7 | Phosphorylation | -MAQTQGTKRKVCYY -CCCCCCCCEEEEEE | 20.19 | - | |
45 | Phosphorylation | THNLLLNYGLYRKME HHHHHHHHHHHHCCE | 14.42 | 24759943 | |
74 | Acetylation | YHSDDYIKFLRSIRP HCCHHHHHHHHHHCC | 31.92 | 22826441 | |
74 | Ubiquitination | YHSDDYIKFLRSIRP HCCHHHHHHHHHHCC | 31.92 | 22790023 | |
87 | Phosphorylation | RPDNMSEYSKQMQRF CCCCHHHHHHHHHHC | 17.54 | - | |
89 | Ubiquitination | DNMSEYSKQMQRFNV CCHHHHHHHHHHCCC | 49.22 | 22790023 | |
89 | Acetylation | DNMSEYSKQMQRFNV CCHHHHHHHHHHCCC | 49.22 | 23806337 | |
220 | Acetylation | DIGAGKGKYYAVNYP ECCCCCCCEEEEECC | 38.28 | 23806337 | |
221 | Phosphorylation | IGAGKGKYYAVNYPL CCCCCCCEEEEECCC | 12.82 | - | |
261 | S-nitrosylation | PSAVVLQCGSDSLSG CCEEEEECCCCCCCC | 5.01 | - | |
261 | S-nitrosocysteine | PSAVVLQCGSDSLSG CCEEEEECCCCCCCC | 5.01 | - | |
263 | Phosphorylation | AVVLQCGSDSLSGDR EEEEECCCCCCCCCC | 31.49 | 25521595 | |
265 | Phosphorylation | VLQCGSDSLSGDRLG EEECCCCCCCCCCEE | 26.57 | 25521595 | |
273 | S-nitrosocysteine | LSGDRLGCFNLTIKG CCCCCEECEEEEECC | 2.12 | - | |
273 | S-nitrosylation | LSGDRLGCFNLTIKG CCCCCEECEEEEECC | 2.12 | - | |
346 | Phosphorylation | PDFKLHISPSNMTNQ CCCEEEECCCCCCCC | 16.13 | 26643407 | |
348 | Phosphorylation | FKLHISPSNMTNQNT CEEEECCCCCCCCCH | 32.23 | 26643407 | |
351 | Phosphorylation | HISPSNMTNQNTNEY EECCCCCCCCCHHHH | 37.59 | 26643407 | |
355 | Phosphorylation | SNMTNQNTNEYLEKI CCCCCCCHHHHHHHH | 21.47 | - | |
361 | Ubiquitination | NTNEYLEKIKQRLFE CHHHHHHHHHHHHHH | 53.24 | 22790023 | |
393 | Phosphorylation | EDAIPEESGDEDEED CCCCCCCCCCCCCCC | 50.29 | 24925903 | |
406 | Phosphorylation | EDPDKRISICSSDKR CCCCCCEEEECCCCE | 22.90 | 23684622 | |
408 | Glutathionylation | PDKRISICSSDKRIA CCCCEEEECCCCEEE | 2.25 | 24333276 | |
409 | Phosphorylation | DKRISICSSDKRIAC CCCEEEECCCCEEEE | 39.64 | 26824392 | |
410 | Phosphorylation | KRISICSSDKRIACE CCEEEECCCCEEEEE | 42.62 | 23684622 | |
412 | Ubiquitination | ISICSSDKRIACEEE EEEECCCCEEEEECC | 47.88 | - | |
412 | Acetylation | ISICSSDKRIACEEE EEEECCCCEEEEECC | 47.88 | 23806337 | |
421 | Phosphorylation | IACEEEFSDSDEEGE EEEECCCCCCCCCCC | 39.21 | 27087446 | |
423 | Phosphorylation | CEEEFSDSDEEGEGG EECCCCCCCCCCCCC | 45.80 | 27087446 | |
432 | Methylation | EEGEGGRKNSSNFKK CCCCCCCCCCHHHHC | 65.54 | - | |
432 | Acetylation | EEGEGGRKNSSNFKK CCCCCCCCCCHHHHC | 65.54 | 8439425 | |
434 | Phosphorylation | GEGGRKNSSNFKKAK CCCCCCCCHHHHCHH | 29.69 | 23684622 | |
435 | Phosphorylation | EGGRKNSSNFKKAKR CCCCCCCHHHHCHHC | 56.53 | 24759943 | |
445 | Phosphorylation | KKAKRVKTEDEKEKD HCHHCCCCHHHHCCC | 45.90 | - |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
421 | S | Phosphorylation |
| - |
423 | S | Phosphorylation |
| - |
444 | K | Sumoylation |
| - |
476 | K | Sumoylation |
| - |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of HDAC1_MOUSE !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large scale localization of protein phosphorylation by use ofelectron capture dissociation mass spectrometry."; Sweet S.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J.; Mol. Cell. Proteomics 8:904-912(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-393; SER-421 ANDSER-423, AND MASS SPECTROMETRY. | |
"The phagosomal proteome in interferon-gamma-activated macrophages."; Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,Thibault P.; Immunity 30:143-154(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-393; SER-421 ANDSER-423, AND MASS SPECTROMETRY. | |
"Solid tumor proteome and phosphoproteome analysis by high resolutionmass spectrometry."; Zanivan S., Gnad F., Wickstroem S.A., Geiger T., Macek B., Cox J.,Faessler R., Mann M.; J. Proteome Res. 7:5314-5326(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-393; SER-421 ANDSER-423, AND MASS SPECTROMETRY. |